X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (37) 37
humans (34) 34
infectious diseases (26) 26
male (21) 21
middle aged (20) 20
aged (19) 19
female (19) 19
adult (15) 15
aged, 80 and over (15) 15
public, environmental & occupational health (15) 15
risk factors (15) 15
infections (11) 11
microbiology (11) 11
nursing (10) 10
young adult (10) 10
america (9) 9
health aspects (9) 9
mycoses (9) 9
retrospective studies (9) 9
adolescent (8) 8
anti-bacterial agents - therapeutic use (8) 8
antifungal agents - therapeutic use (8) 8
drug contamination (8) 8
abstracts (7) 7
diagnosis (7) 7
drug therapy (7) 7
immunology (7) 7
abridged index medicus (6) 6
adults (6) 6
antibiotics (6) 6
complications and side effects (6) 6
contamination (6) 6
disease outbreaks (6) 6
fungal infections (6) 6
medicine, general & internal (6) 6
meningitis (6) 6
pharmacology & pharmacy (6) 6
antifungal agents - adverse effects (5) 5
clinical-practice guidelines (5) 5
epidemiology (5) 5
infection (5) 5
methylprednisolone (5) 5
methylprednisolone - administration & dosage (5) 5
methylprednisolone - adverse effects (5) 5
michigan (5) 5
outbreak (5) 5
research (5) 5
voriconazole (5) 5
anti-bacterial agents - pharmacology (4) 4
antifungal agents - administration & dosage (4) 4
aspergillosis (4) 4
candidiasis - drug therapy (4) 4
diarrhea (4) 4
diseases society (4) 4
dosage and administration (4) 4
guideline adherence (4) 4
guidelines (4) 4
michigan - epidemiology (4) 4
mycoses - drug therapy (4) 4
united states - epidemiology (4) 4
alopecia (3) 3
amphotericin-b (3) 3
analysis (3) 3
animals (3) 3
antimicrobials (3) 3
aspergillosis - drug therapy (3) 3
association (3) 3
bacteria (3) 3
bacteriuria - drug therapy (3) 3
catheters (3) 3
clostridium difficile - drug effects (3) 3
clostridium difficile infection (3) 3
clostridium infections - drug therapy (3) 3
clostridium infections - microbiology (3) 3
corticosteroids (3) 3
disease control (3) 3
diseases-society (3) 3
fluconazole (3) 3
health-care epidemiology (3) 3
hospitalization (3) 3
hospitals (3) 3
impact (3) 3
infection control (3) 3
infectious disease (3) 3
injections, epidural (3) 3
injections, spinal (3) 3
invasive fungal-infections (3) 3
long-term care (3) 3
magnetic resonance imaging (3) 3
major (3) 3
major articles (3) 3
management (3) 3
medical treatment (3) 3
medicine & public health (3) 3
meningitis, fungal - epidemiology (3) 3
metronidazole (3) 3
pneumonia (3) 3
prevalence (3) 3
public health (3) 3
skin (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 11/2019, Volume 69, Issue 11, pp. 2043 - 2044
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 02/2019, Volume 47, Issue 2, pp. 170 - 174
It is recommended that that only unformed stool from patients with diarrhea be tested for infection. We determined the prevalence of and patient... 
Orders | Diagnostic Stewardship | Clostridium difficile infection | Colonization | INFECTIOUS DISEASES | GUIDELINES | PREVALENCE | CARRIERS | CHILDREN | IMPACT | TRANSMISSION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | VANCOMYCIN | DISEASE | INFECTION | METRONIDAZOLE | Hospital patients | Usage | Polyethylene glycol | Diarrhea | Medical tests | Adults | Diagnosis | Magnesium hydroxide | Polyols
Journal Article
The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 03/2016, Volume 71, Issue 3, p. 836
  The study objective was to determine whether there was an improvement in compliance with recommended Clostridium difficile infection (CDI) treatment after... 
Bacterial infections | Gram-positive bacteria | Antimicrobial agents | Patient admissions | Drug therapy
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2014, Volume 59, Issue 3, p. E61
  Voriconazole was 1 of 2 antifungal agents recommended for treatment of fungal infections associated with injection of contaminated methylprednisolone.... 
Side effects | Alopecia | Fungal infections | Drug therapy | Hair loss
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2014, Volume 59, Issue 3, pp. E61 - E61
Voriconazole was 1 of 2 antifungal agents recommended for treatment of fungal infections associated with injection of contaminated methylprednisolone. Alopecia... 
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S362 - S363
Abstract Background Antimicrobial stewardship team (AST) surveillance at our hospital is facilitated by an internally-developed database. In 2013, the database... 
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2014, Volume 59, Issue 9, p. 1237
  Voriconazole is a triazole antifungal medication used for prophylaxis or to treat invasive fungal infections. Inflammation of the periosteum resulting in... 
Musculoskeletal diseases | Plasma | Pain | Molecular structure | Fluorides | Fungal infections
Journal Article
Current infectious disease reports, ISSN 1523-3847, 01/2015, Volume 17, Issue 1, p. 441
In September 2012, an unprecedented outbreak of fungal infections due to preservative-free, injectable methylprednisolone acetate (MPA) was identified.... 
Journal Article
Journal of Cardiac Surgery, ISSN 0886-0440, 11/2009, Volume 24, Issue 6, pp. 763 - 765
Journal Article
American Journal of Infection Control, ISSN 0196-6553, 02/2013, Volume 41, Issue 2, pp. 145 - 145
Data from community antimicrobial stewardship programs (ASPs) are limited. We describe clinical and economic outcomes from the first year of our hospital's... 
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0182815
Background Clostridium difficile infection (CDI) is a significant nosocomial infection worldwide, that recurs in as many as 35% of infections. Risk of CDI... 
RELAPSE | VANCOMYCIN | FIDAXOMICIN | MULTIDISCIPLINARY SCIENCES | DISEASE | MICROBIOTA | SPORULATION | GERMINATION | HUMAN GUT MODEL | TOXIN PRODUCTION | EPIDEMIOLOGY | Recurrence | Clostridium difficile - classification | Drug Administration Schedule | Humans | Clostridium difficile - genetics | Spores, Bacterial - pathogenicity | Models, Statistical | Bacterial Toxins - antagonists & inhibitors | Clostridium Infections - pathology | Microbial Sensitivity Tests | Bacterial Toxins - biosynthesis | Clostridium Infections - microbiology | Drug Dosage Calculations | Vancomycin - pharmacokinetics | Ribotyping | Computer Simulation | Vancomycin - pharmacology | Anti-Bacterial Agents - pharmacokinetics | Spores, Bacterial - growth & development | Spores, Bacterial - drug effects | Clostridium Infections - drug therapy | Clostridium difficile - growth & development | Anti-Bacterial Agents - pharmacology | Clostridium difficile - drug effects | Treatment outcome | Relapse | Clostridium infections | Analysis | Dosage and administration | Research | Vancomycin | Drug therapy | Risk factors | Diseases | Nosocomial infection | Risk | Infections | Dosage | Epidemiology | Spores | Cost-benefit analysis | Sporulation | Mathematical models | Public health | Pathogens | Computer simulation | Recurrent infection | Mortality | Germination | Risk reduction | Antimicrobial agents | Disease control | Pathogenicity | Chemotherapy | Hospitals | Vegetative cells | Antibiotics | Ordinary differential equations | Toxins
Journal Article
Infectious Diseases in Clinical Practice, ISSN 1056-9103, 07/2012, Volume 20, Issue 4, pp. 278 - 279
ABSTRACTWe report pulmonary cryptococcosis in an elderly man. His cat was found to have cryptococcosis 2 months earlier. Our case highlights the importance of... 
Cryptococcus | pulmonary | cats | animals | cryptococcosis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.